Components: (5S)-(−)-2,2,3-Trimethyl-5-benzyl-4-imidazolidinone monohydrochloride, 97% 500 mg; (S)-(+)-2-(tert-Butyl)-3-methyl-4-imidazolidinone trifluoroacetic acid, 96% 500 mg; (5S)-(−)-2,2,3-Trimethyl-5-benzyl-4-imidazolidinone dichloroacetic acid, 97% 500 mg; (2S,5S)-(−)-2-tert-Butyl-3-methyl-5-benzyl-4-imidazolidinone, 97% 500 mg; (2S,5S)-(–)-5-Benzyl-3-methyl-2-(5-methyl-2-furyl)-4-imidazolidinone, 95% 250 mg
Signal Word: Danger
Hazard statements: H301-H315-H318-H335
Precautionary statements: P261-P280-P301 + P310-P305 + P351 + P338
Risk Statements (Europe): 25-37/38-41
Safety Statements (Europe): 26-39-45
Hazard Codes (Europe): T